Efruxifermin Fast Tracked for Nonalcoholic Steatohepatitis
Efruxifermin is a differentiated Fc-FGF21 fusion protein designed to mimic the biological activity of fibroblast growth factor 21.
Obesity
Intermittent Fasting Is a Safe Diet Pattern for T2D and Metabolic Syndrome
Intermittent fasting can be safe and effective for glycemic control in patients with type 2 diabetes or metabolic syndrome, according to research results published in Diabetes Research and Clinical Practice.
Childhood Body Size May Affect Cardiovascular Disease Outcomes in Adulthood
Larger body size during childhood was found to have direct causal effect on CVD outcomes in adulthood.
Greater Weight Loss After Bariatric Surgery Tied to Diabetes Remission
However, above 20 percent total weight loss, rates of initial diabetes remission do not increase substantially.
AHA Scientific Statement Addresses Weight Loss Strategies for Hypertension Prevention and Treatment
The American Heart Association released a scientific statement reviewing weight loss strategies for the prevention and treatment of hypertension.
Sharp Increase in BMI Rates Noted for Children During Pandemic
Approximate doubling in rate of BMI increase seen between prepandemic and pandemic periods; higher increases reported for those with overweight, obesity.
Frequency of Long-Term Symptoms Up With Positive SARS-CoV-2 Test
Persistence of more than four weeks of at least one initially occurring symptom among 76.2 percent of those with positive test.
How Obesity Affects Body Composition, Frailty, and Pain in Older Patients
GAPNA discusses how advanced practice practitioners are well-positioned to encourage healthy lifestyles among older adults, to include activities that help attain/maintain lean muscle mass, regardless of BMI, to reduce chronic pain and frailty.
Combined Exercise, Liraglutide Therapy Improved Weight Loss Maintenance
Investigators evaluated the effectiveness of a 1-year moderate to vigorous exercise program, liraglutide treatment, or the combination of both, compared with placebo, for the maintenance of healthy weight loss.
Prevalence of Obesity, Overweight High in Coronary Heart Disease
The prevalence of obesity and overweight is high among patients with coronary heart disease (CHD), and many patients do not lose weight after discharge from CHD-related hospitalization.
- Loading...
Loading...
Loading... 
Loading...